Addus HomeCare Corporation ADUS
125.65 USD -0.91 (-0.72%)
Nov 4, 2026, 10:40 AM EST
120.52 Day range 125.82
87.95 52-week range 127.08
- YTD
- +17.00%
- 1 year
- +11.96%
Analyst view
Consensus: buy
Buy
Price target (mean) 134.08 +6.7% upside
Now 125.65
- Target (low)
- 96.00
- Target (mean)
- 134.08
- Target (high)
- 155.00
Ratings (0m) 14 11 buy · 2 hold · 1 sell
- Strong buy3
- Buy8
- Hold2
- Sell0
- Strong sell1
Recommendation trend
- This month 14
- 1 month ago 14
- 2 months ago 14
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.79 | 1.75 – 1.86 | 1.56 | +14.9% | 388.69M | +7.3% | 13 |
| Next quarter | 1.89 | 1.84 – 1.94 | 1.77 | +7.0% | 393.84M | +5.6% | 13 |
| Current year | 7.05 | 6.96 – 7.14 | 6.23 | +13.1% | 1.52B | +7.1% | 14 |
| Next year | 7.52 | 7.30 – 7.67 | 7.05 | +6.7% | 1.60B | +4.8% | 13 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 14, 2026 | B of A Securities | Downgrade | Buy | Neutral |
| Aug 5, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 9, 2026 | Barclays | Maintained | Underweight | Underweight |
| May 18, 2026 | Citizens | Reiterated | Market Outperform | Market Outperform |
| May 15, 2026 | Barclays | Maintained | Underweight | Underweight |
| May 6, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Mar 25, 2026 | Barclays | Maintained | Underweight | Underweight |
| Feb 25, 2026 | Stephens & Co. | Maintained | Overweight | Overweight |
| Feb 24, 2026 | Barclays | Maintained | Underweight | Underweight |
| Nov 13, 2025 | BMO Capital | Initiated | — | Market Perform |
| Nov 7, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 5, 2025 | TD Cowen | Maintained | Buy | Buy |
| Nov 4, 2025 | Barclays | Maintained | Underweight | Underweight |
| Sep 3, 2025 | Stephens & Co. | Reiterated | Overweight | Overweight |
| Sep 2, 2025 | UBS | Initiated | — | Buy |
| Aug 22, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 19, 2025 | Barclays | Maintained | Underweight | Underweight |
| Aug 6, 2025 | TD Cowen | Maintained | Buy | Buy |
| Jul 31, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 16, 2025 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Jun 20, 2025 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Jun 10, 2025 | Macquarie | Maintained | Outperform | Outperform |
| May 8, 2025 | Macquarie | Maintained | Outperform | Outperform |
| Apr 22, 2025 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Apr 10, 2025 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Mar 12, 2025 | Stephens & Co. | Reiterated | Overweight | Overweight |
| Feb 27, 2025 | Macquarie | Maintained | Outperform | Outperform |
| Feb 26, 2025 | Stephens & Co. | Maintained | Overweight | Overweight |
| Jan 24, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Dec 16, 2024 | JMP Securities | Initiated | — | Market Outperform |